The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Stoudemire, A.
* Articles by Clayton, L.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Stoudemire, A.
* Articles by Clayton, L.

J Neuropsychiatry Clin Neurosci 1989; 1:303-305
Copyright © 1989 by American Neuropsychiatric Association


REGULAR ARTICLES

Successful use of clozapine in a patient with a history of neuroleptic malignant syndrome

A Stoudemire and L Clayton
Medical Psychiatry Unit, Emory University Hospital, Atlanta, Georgia.

Reinstitution of antipsychotic medication is problematic in patients with a history of neuroleptic malignant syndrome (NMS). In this case, a patient with a history of probable neuroleptic malignant syndrome caused by administration, as single agents, of haloperidol, molindone, and lithium was later treated successfully with the novel antipsychotic clozapine. The propensity of various antipsychotic agents to cause NMS is discussed.





Get information about faster international access.

Privacy Policy

Copyright © 1989 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org